TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Return on Sales [ROS] (2023)

Updated

TFA Therapeutics (RAJAF) posted Return on Sales [ROS] of -11.33% for FY2025, up 3.34 percentage points from -14.67% in FY2024.

Analysis

TFA Therapeutics (RAJAF) Return on Sales [ROS] (2023) Analysis & Trends

Since FY2020, TFA Therapeutics has reported Return on Sales [ROS] for 6 years.

  • Annual Return on Sales [ROS] shows a five-year change of -17.81 percentage points (FY2020 to FY2025).
  • Annual Return on Sales [ROS] has run from a low of -778.78% in FY2022 to a high of 25.82% in FY2023 over five years.
  • Business Quant data shows RAJAF's Return on Sales [ROS] at -14.67% in FY2024 (-40.49 pp), 25.82% in FY2023 (+804.60 pp), -778.78% in FY2022 (-765.20 pp) and -13.58% in FY2021 (-20.06 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn 18.63%
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn 18.95%
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn -1.08%
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn 17.67%
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn 15.11%
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn 18.07%
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn 24.33%
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn 21.37%
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn 14.62%
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 38.18%
API Access

TFA Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RAJAF&period=max&api_key=YOUR_API_KEY